Darvadstrocel (Alofisel) – indicated for the treatment of complex perianal fistulas caused by Crohn's disease – is the first allogeneic stem‐cell therapy to be approved in the EU. This article… Click to show full abstract
Darvadstrocel (Alofisel) – indicated for the treatment of complex perianal fistulas caused by Crohn's disease – is the first allogeneic stem‐cell therapy to be approved in the EU. This article examines its administration, efficacy and place in therapy.
               
Click one of the above tabs to view related content.